SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
ModeX Therapeutics, An OPKO Health Company
LTZ Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Istituto Oncologico Veneto IRCCS
University of Arizona
Ipsen
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Nebraska
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Insel Gruppe AG, University Hospital Bern
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Ipsen
The First Affiliated Hospital of Xiamen University
Cyteir Therapeutics, Inc.
Australasian Leukaemia and Lymphoma Group
Atara Biotherapeutics
Roswell Park Cancer Institute
Swiss Cancer Institute
Gilead Sciences
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Novartis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
Roswell Park Cancer Institute